Pharma Mar | PHM - Ebitda

Aktienkurs
94.65
Täglich Wechseln
-2.30 -2.37%
Monatlich
5.64%
Jährlich
30.10%
Q2 Prognose
92.25




Ebitda Veränderung Datum
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Almirall EUR 114.07M 60.37M 2025-12
Avita Medical AUD -9.69M 12.21M 2025-12
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
IQVIA Holdings USD 1.05B 97M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Moderna USD -790M 582M 2025-12
Organon & Co USD 383M 135M 2025-12
Pharma Mar EUR 44.96M 46.94M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Tectonic Therapeutic USD -21.18M 365K 2025-12
Viatris USD 1B 151.5M 2025-12
Xeris Pharmaceuticals USD 25.09M 7.67M 2025-12